2020
DOI: 10.1155/2020/3509064
|View full text |Cite
|
Sign up to set email alerts
|

Objective Imaging Diagnostics for Dry Eye Disease

Abstract: Traditional diagnostic tests for dry eye disease (DED), such as fluorescein tear film break-up time and the Schirmer test, are often associated with poor reproducibility and reliability, which make the diagnosis, follow-up, and management of the disease challenging. Advances in ocular imaging technology enables objective and reproducible measurement of changes in the ocular surface, tear film, and optical quality associated with DED. In this review, the authors will discuss the application of various imaging t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
34
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(35 citation statements)
references
References 124 publications
(206 reference statements)
0
34
0
1
Order By: Relevance
“…More reproducible and reliable tests, such as tear osmolarity, tear cytokine level, impression cytology, and in vivo confocal microscopy have been introduced for assessment of DED, which may be helpful for more accurate evaluation of the influence of PUFAs on DED [24,54,56,64,65]. Newly developed objective test methods for DED, such as anterior segment optical coherence tomography, non-invasive tear breakup time, interferometry, tear film imager, meibography, and thermometry are shown to allow more reproducible and accurate measurement of biomarkers of DED, such as tear volume, thickness, height and stability, meibomian gland function, thickness of tear muco-aqueous and lipid layers, and ocular surface temperature [101].Therefore, application of these devices is expected to enable the evaluation of the real efficacy of various PUFAs on DED [101].…”
Section: Current Perspectivesmentioning
confidence: 99%
“…More reproducible and reliable tests, such as tear osmolarity, tear cytokine level, impression cytology, and in vivo confocal microscopy have been introduced for assessment of DED, which may be helpful for more accurate evaluation of the influence of PUFAs on DED [24,54,56,64,65]. Newly developed objective test methods for DED, such as anterior segment optical coherence tomography, non-invasive tear breakup time, interferometry, tear film imager, meibography, and thermometry are shown to allow more reproducible and accurate measurement of biomarkers of DED, such as tear volume, thickness, height and stability, meibomian gland function, thickness of tear muco-aqueous and lipid layers, and ocular surface temperature [101].Therefore, application of these devices is expected to enable the evaluation of the real efficacy of various PUFAs on DED [101].…”
Section: Current Perspectivesmentioning
confidence: 99%
“…Best corrected visual acuity (BCVA) was used as an indicator of visual stability. CFS, TBUT, and the Schirmer test without topical anesthesia (Schirmer I) were used to assess the lubricating properties, stability, and quantity of the tear film [43][44][45][46][47]. Tear film osmolarity in the lower tear meniscus was additionally measured using the TearLab osmolarity system (TearLab Corporation, San Diego, CA, USA).…”
Section: Efficacy Assessmentmentioning
confidence: 99%
“…Infrared thermography (IRT) in the medical setting has been used to noninvasively assess the surface temperature of various body parts, organs, tissues, and cells for indication of abnormality [ 16 19 ]. It has gained popularity in medical diagnostics and research since the 1960s due to its nonionizing and noninvasive nature [ 20 , 21 ]. To date, studies have successfully reported the capability of IRT in screening breast cancer, diabetic neuropathy, mass fever screening, and meibomian gland dysfunction [ 22 25 ].…”
Section: Introductionmentioning
confidence: 99%